Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 41 | $61,610,449 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
30 Mar 2023 21:04 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 29 Mar 2023 | Sale | 41,242 | 16 | 659,872 | D |
30 Mar 2023 21:04 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 28 Mar 2023 | Sale | 196,563 | 15 | 2,948,445 | D |
03 Apr 2023 19:24 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 Apr 2023 | Sale | 30,911 | 18 | 556,398 | D |
03 Apr 2023 19:24 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 30 Mar 2023 | Sale | 131,029 | 17.0025 | 2,227,821 | D |
03 Apr 2023 19:26 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 03 Apr 2023 | Sale | 22,000 | 17.85 | 392,700 | D |
03 Apr 2023 19:26 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 31 Mar 2023 | Sale | 67,970 | 17.45 | 1,186,076 | D |
03 Apr 2023 19:26 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Mar 2023 | Sale | 65,382 | 17.45 | 1,140,916 | D |
03 Apr 2023 19:26 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Mar 2023 | Sale | 88,000 | 16.95 | 1,491,600 | D |
13 Apr 2023 17:13 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 12 Apr 2023 | Sale | 41,544 | 18 | 747,792 | D |
13 Apr 2023 17:13 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 11 Apr 2023 | Sale | 56,295 | 18.0037 | 1,013,518 | D |
13 Apr 2023 17:14 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 13 Apr 2023 | Sale | 79,336 | 18.45 | 1,463,749 | D |
18 Apr 2023 19:07 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 17 Apr 2023 | Sale | 7,500 | 20 | 150,000 | D |
18 Apr 2023 19:08 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 17 Apr 2023 | Sale | 12,500 | 20 | 250,000 | D |
18 Apr 2023 19:09 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 17 Apr 2023 | Sale | 155,000 | 20.4501 | 3,169,766 | D |
18 Apr 2023 19:10 | VKTX | Viking Therapeutics Inc | MACARTNEY LAWSON | Director | 17 Apr 2023 | Sale | 20,786 | 20 | 415,720 | D |
21 Apr 2023 19:29 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 19 Apr 2023 | Sale | 35,000 | 21.45 | 750,750 | D |
24 Apr 2023 19:31 | VKTX | Viking Therapeutics Inc | MACARTNEY LAWSON | Director | 24 Apr 2023 | Sale | 16,000 | 22.0038 | 352,061 | D |
01 May 2023 19:03 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 01 May 2023 | Sale | 45,000 | 22.45 | 1,010,250 | D |
18 May 2023 18:30 | VKTX | Viking Therapeutics Inc | MACARTNEY LAWSON | Director | 16 May 2023 | Sale | 16,000 | 24 | 384,000 | D |
18 May 2023 18:31 | VKTX | Viking Therapeutics Inc | ROWLAND CHARLES A JR | Director | 16 May 2023 | Sale | 40,000 | 25 | 1,000,000 | D |
04 Jan 2024 21:35 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 04 Jan 2024 | Sale | 15,000 | 17.9 | 268,500 | D |
19 Jan 2024 20:35 | VKTX | Viking Therapeutics Inc | ROUAN SARAH KATHRYN | Director | 19 Jan 2024 | Sale | 30,000 | 23.05 | 691,500 | D |
30 Jan 2024 21:05 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Jan 2024 | Sale | 35,000 | 23.95 | 838,250 | D |
31 Jan 2024 20:39 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 31 Jan 2024 | Sale | 40,000 | 24.45 | 978,000 | D |
31 Jan 2024 20:39 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 31 Jan 2024 | Sale | 45,000 | 24.95 | 1,122,750 | D |
08 Feb 2024 19:38 | VKTX | Viking Therapeutics Inc | ROUAN SARAH KATHRYN | Director | 08 Feb 2024 | Sale | 25,000 | 28.05 | 701,250 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 40,000 | 28.9 | 1,156,000 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 40,000 | 27.45 | 1,098,000 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 80,000 | 26.95 | 2,156,000 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 60,000 | 25.95 | 1,557,000 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 49,079 | 25.75 | 1,263,784 | D |
09 Feb 2024 20:59 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 09 Feb 2024 | Sale | 45,000 | 29.9 | 1,345,500 | D |
02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 6,248 | 80.0753 | 500,310 | D |
02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 105,343 | 78.6476 | 8,284,974 | D |
02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 119,946 | 79.2945 | 9,511,058 | D |
02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 26,142 | 77.4933 | 2,025,830 | D |
02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 23,746 | 76.4045 | 1,814,301 | D |
03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 847 | 76.0743 | 64,435 | D |
03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 17,238 | 75.4868 | 1,301,241 | D |
03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 45,570 | 74.4447 | 3,392,445 | D |
03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 3,101 | 73.4881 | 227,887 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)